Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Evaluation and Assessment of Instruments and Biomarkers in Subjects With Wilson Disease

NCT04531189 is registered in ClinicalTrials.gov with Ultragenyx Pharmaceutical Inc as lead sponsor.

NCT NCT04531189
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04531189 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Evaluation and Assessment of Instruments and Biomarkers in Subjects With Wilson Disease
Lead sponsor
Ultragenyx Pharmaceutical Inc
Phase
Observational
Overall status
Completed
Start date
December 11, 2020
Completion date
March 25, 2022
Enrollment
16 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

wilson disease